{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:14:15Z","timestamp":1791497655023,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.coviro.2012.02.017","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T07:27:44Z","timestamp":1333006064000},"page":"315-323","source":"Crossref","is-referenced-by-count":97,"title":["Breaking the chain: Rift Valley fever virus control via livestock vaccination"],"prefix":"10.1016","volume":"2","author":[{"given":"Brian H","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2012.02.017_bib0005_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0010","series-title":"Rift Valley Fever","author":"Swanepoel","year":"1994"},{"key":"10.1016\/j.coviro.2012.02.017_bib0015","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1128\/JVI.01519-08","article-title":"Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006\u20132007","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0020_1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4269\/ajtmh.2010.09-0669","article-title":"Severe Rift Valley fever may present with a characteristic clinical syndrome","volume":"82","author":"Kahlon","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2012.02.017_bib0030","first-page":"1047","article-title":"Acute renal failure associated with the Rift Valley fever: a single center study","volume":"20","author":"El Imam","year":"2009","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.coviro.2012.02.017_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.coviro.2012.02.017_bib0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.coviro.2012.02.017_bib0045_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.coviro.2012.02.017_bib0050","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.coviro.2012.02.017_bib0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0060","volume":"vol. IV","author":"Meegan","year":"1989"},{"key":"10.1016\/j.coviro.2012.02.017_bib0065","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.3823909","article-title":"Detection of Rift Valley fever viral activity in Kenya by satellite remote sensing imagery","volume":"235","author":"Linthicum","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.coviro.2012.02.017_bib0070","first-page":"551","article-title":"The horizontal distribution of Aedes pupae and their subsequent adults within a flooded dambo in Kenya: implications for Rift Valley fever virus control","volume":"4","author":"Linthicum","year":"1988","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"10.1016\/j.coviro.2012.02.017_bib0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0022172400062434","article-title":"Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya","volume":"95","author":"Linthicum","year":"1985","journal-title":"J. Hyg. (Lond.)"},{"key":"10.1016\/j.coviro.2012.02.017_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jmedent\/24.1.11","article-title":"Transmission studies in mosquitoes (Diptera: Culicidae) with disseminated Rift valley fever virus infections","volume":"24","author":"Turell","year":"1987","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0085","first-page":"100","article-title":"Rift Valley fever in Egypt: an overview of the epizootics in 1977 and 1978","volume":"3","author":"Meegan","year":"1981","journal-title":"Contrib. Epidemiol. Biostat."},{"key":"10.1016\/j.coviro.2012.02.017_bib0090","first-page":"114","article-title":"Clinical experience with Rift Valley fever in humans during the 1977 egyptian epizootic","volume":"3","author":"Meegan","year":"1981","journal-title":"Contrib. Epidemiol. Biostat."},{"key":"10.1016\/j.coviro.2012.02.017_bib0095","first-page":"867","article-title":"Rift Valley fever affecting humans in South Africa: a clinicopathological study","volume":"51","author":"van Velden","year":"1977","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.coviro.2012.02.017_bib0100","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1016\/j.vaccine.2008.07.094","article-title":"Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: not missing the opportunities","volume":"26","author":"Nara","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4269\/ajtmh.2010.09-0291","article-title":"An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya","volume":"83","author":"Rich","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.coviro.2012.02.017_bib0110_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/vbz.2010.0200","article-title":"Rift Valley fever epidemiology, surveillance, and control: what have models contributed?","volume":"11","author":"Metras","year":"2011","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/153036604773082979","article-title":"Mapping Rift Valley Fever vectors and prevalence using rainfall variations","volume":"4","author":"Bicout","year":"2004","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0120","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1365-3156.2006.01746.x","article-title":"Rift Valley fever in West Africa: the role of space in endemicity","volume":"11","author":"Favier","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.coviro.2012.02.017_bib0125","unstructured":"Xue L, Scott MH, Scoglio C: A network-based meta-population approach to model Rift Valley fever epidemics. ArXiV. http:\/\/arxiv.org\/PS_cache\/arxiv\/pdf\/1012\/1012.1684v2.pdf; 2011."},{"key":"10.1016\/j.coviro.2012.02.017_bib0130","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0135_1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.0806490106","article-title":"Prediction of a Rift Valley fever outbreak","volume":"106","author":"Anyamba","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.coviro.2012.02.017_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-072X-5-60","article-title":"Developing global climate anomalies suggest potential disease risks for 2006\u20132007","volume":"5","author":"Anyamba","year":"2006","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.coviro.2012.02.017_bib0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/fvl.10.63","article-title":"Towards a safe, effective vaccine for Rift Valley fever virus","volume":"5","author":"Labeaud","year":"2010","journal-title":"Future Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/vbz.2010.0040","article-title":"Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we?","volume":"10","author":"Kortekaas","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.coviro.2012.02.017_bib0155","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0160","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.07104-11","article-title":"Single dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","author":"Dodd","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0170","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(\u2212\/\u2212) mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0175_1","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.vaccine.2010.01.001","article-title":"Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0180","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0185","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pntd.0000725","article-title":"Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus","volume":"4","author":"Bhardwaj","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2012.02.017_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.coviro.2012.02.017_bib0200","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00182-09","article-title":"A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity","volume":"16","author":"Holman","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0205","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.coviro.2012.02.017_bib0210","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0215","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0220_1","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0225","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/CVI.00220-10","article-title":"Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine","volume":"17","author":"Soi","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0230","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.coviro.2012.02.017_bib0235","unstructured":"Office des International Epizooties O: Terrestrial Code-Rift Valley fever 8.11, vol. 2; 2011."},{"key":"10.1016\/j.coviro.2012.02.017_bib0240","unstructured":"Office des International Epizooties O: Integrated Control of Neglected Zoonotic Diseases in Africa; 2007 (http:\/\/www.oie.int\/doc\/ged\/D6794.PDF; accessed 01\/18\/2012)."},{"key":"10.1016\/j.coviro.2012.02.017_bib0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.prevetmed.2011.04.007","article-title":"Brucellosis at the animal\/ecosystem\/human interface at the beginning of the 21st century","volume":"102","author":"Godfroid","year":"2011","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.coviro.2012.02.017_bib0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10540-007-9057-9","article-title":"Animal and human health implications of avian influenza infections","volume":"27","author":"Capua","year":"2007","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.coviro.2012.02.017_bib0255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/vr.d5378","article-title":"One health and the neglected zoonoses: turning rhetoric into reality","volume":"169","author":"Okello","year":"2011","journal-title":"Vet. Rec."},{"key":"10.1016\/j.coviro.2012.02.017_bib0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1473-3099(10)70312-1","article-title":"Towards a conceptual framework to support one-health research for policy on emerging zoonoses","volume":"11","author":"Coker","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.coviro.2012.02.017_bib0265","first-page":"155","article-title":"Rift Valley fever vaccine\u2014antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"Barnard","year":"1979","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"10.1016\/j.coviro.2012.02.017_bib0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J. Immunol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"Jansen van Vuren","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.coviro.2012.02.017_bib0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.coviro.2012.02.017_bib0285","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2012.02.017_bib0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jviromet.2010.07.015","article-title":"Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles","volume":"169","author":"Mandell","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.coviro.2012.02.017_bib0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2012.02.017_bib0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jviromet.2007.06.004","article-title":"Improved method for the generation and selection of homogeneous lumpy skin disease virus (SA-Neethling) recombinants","volume":"146","author":"Wallace","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.coviro.2012.02.017_bib0305","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0310","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2004.10.006","article-title":"Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion","volume":"23","author":"Wallace","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.017_bib0315","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625712000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625712000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T05:44:15Z","timestamp":1742795055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625712000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1879625712000454"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2012.02.017","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}